TLPH Q4 2019 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena

TLPHTalphera, Inc.

$18M

Q4 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$475,000-22.5% YoY

Gross Profit

-$2M-464.4% margin

Operating Income

-$15M-3156.2% margin

Net Income

-$14M-3036.4% margin

EPS (Diluted)

$-3.63

QoQ Revenue Growth

-21.9%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$14M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$91M

Total Liabilities

$133M

Stockholders' Equity

-$41M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$475,000	$613,000	-22.5%
Gross Profit	-$2M	-$3M	+33.7%
Operating Income	-$15M	-$11M	-36.6%
Net Income	-$14M	-$13M	-14.9%